Journal of Carbohydrates

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Carbohydrates-Metabolism-Selvihan Beysel

Turkey

Clinical Endocrinologist,
Department of Endocrinology and Metabolism,
Eskisehir State Hospital, Eskişehir, Turkey.

05537465802

Send an Email

Selvihan Beysel

Address:

Hacıalibey Street, 
No.35/2 Tepebaşı Eskişehir,
Turkey.

Research Interests:

  • Metabolism
  • Diabetes
  • Metabolic Diseases
  • Lipid Metabolism
  • Diabetes Mellitus
  • Metabolic Syndrome
  • Clinical Endocrinology
  • Metabolic Endocrinology.

Biography:

Publications:

  1. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. Akaslan Beysel S, Degertekin CK, Yilmaz G, Cakir N, Arslan M, Toruner FB. Metab Syndr Relat Disord. 2013 Aug;11(4):243-50. doi: 10.1089/met.2012.0128. (İç hastalıkları uzmanlık tezi)
  2. Evaluation of prehypertension and masked hypertension rate among clinically normotensive patients. Unsal S, Ozkara A, Albayrak T, Ozturk Y, Beysel S, Kucukler FK. Clin Exp Hypertens. 2016;38(2):218-24. doi: 10.3109/10641963.2015.1047951.
  3. Visceral Obesity Mediates the Association Between Metabolic Syndrome and Obstructive Sleep Apnea Syndrome. Bozkurt NC, Beysel S, Karbek B, Unsal İO, Cakir E, Delibasi T. Metab Syndr Relat Disord. 2016 May;14(4):217-21. doi: 10.1089/met.2015.0086.
  4. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease. Beysel S, Kizilgul M, Ozbek M, Caliskan M, Kan S, Apaydin M, Ozcelik O, Cakal E. Clin Interv Aging. 2017 Dec 5;12:2063-2068. doi: 10.2147/CIA.S137247.
  5. PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS. Kizilgul M, Beysel S, Ozcelik O, Kan S, Apaydin M, Caliskan M, Ucan B, Sencar E, Ozdemir S, Cakal E. Endocr Pract. 2017 Jun;23(6):662-668. doi: 10.4158/EP161713.
  6. Tear Film and Ocular Surface Evaluation in Gestational Diabetes Mellitus. Kan S, Acar U, Kizilgul M, Beyazyildiz E, Cankaya AB, Apaydin M, Beysel S, Ozbek M. Semin Ophthalmol. 2016 Dec 22:1-5. doi: 10.1080/08820538.2016.1250919.
  7. Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not? Kizilgul M, Ozcelik O, Beysel S, Akinci H, Kan S, Ucan B, Apaydin M, Cakal E. BMC Endocr Disord. 2017 Oct 6;17(1):62. doi: 10.1186/s12902-017-0212-4.
  8. Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes? Kizilgul M, Kan S, Beysel S, Apaydin M, Ozcelik O, Caliskan M, Ozbek M, Ozdemir S, Cakal E. Arch Endocrinol Metab. 2017 Sep 18:0. doi: 10.1590/2359-3997000000287.
  9. Vitamin D Replacement Improves Tear Osmolarity in Patients with Vitamin D Deficiency. Kizilgul M, Kan S, Ozcelik O, Beysel S, Apaydin M, Ucan B, Cakal E. Semin Ophthalmol. 2017 Sep 6:1-6. doi: 10.1080/08820538.2017.1358752.
  10. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Beysel S. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi:10.1056/NEJMoa1607141.